Episode 19: Reimagining Cancer Drug Development

In this episode, we discuss the way cancer drug development can be reimagined using AI and machine learning. Traditional drug development faces a high failure rate, highlighting the importance of understanding a drug's mechanism of action to improve success rates. AI and computational models that analyze data from various modalities, such as genomics and clinical information, can identify novel targets and enhance precision medicine. Advancements in data availability, especially in the clinic, and a deeper biological understanding are fundamental to revolutionize future drug discovery.

Guest: David Li, Co-Founder and CEO, Meliora Therapeutics, Inc.